Evidence map›Paper›PMID 24919844›Full record

ArticleBMC infectious diseases2014

Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility.

Vanusa G Dutra, Valéria M N Alves, André N Olendzki, Cicero A G Dias, Alessandra F A de Bastos, Gianni O Santos, Efigênia L T de Amorin, Meireille  B Sousa, Rosemary Santos, Patricia C S Ribeiro and 17 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
10.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 124 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Dairy FarmPathogens (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genomic characterization of group BMicrobial genomics · 2025
    Article
  10. Genomic features and pathogenic potential ofJournal of advanced veterinary and animal research · 2025
    Article
  11. Article
  12. A Comparative Analysis of Molecular Epidemiology and Antibiotic Resistance in Group B Streptococcus Isolated From Invasive and Noninvasive Adult Cases in Daejeon, South Korea.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
  13. Article
  14. Changes in Group BPathogens (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Article
  17. Antimicrobial Resistance among Beta-HemolyticAntibiotics (Basel, Switzerland) · 2021
    Review
  18. Phylogeny, recombination, and invasiveness of group B Streptococcus revealed by genomic comparisons of its global strains.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  19. Streptococcus agalactiae strains isolated from cancer patients in Rio de Janeiro, Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 13 institutions in 1 country.

Vanusa G Dutra
Valéria M N Alves
André N Olendzki
Cicero A G Dias
Alessandra F A de Bastos
Gianni O Santos
Efigênia L T de Amorin
Meireille  B Sousa
Rosemary Santos
Patricia C S Ribeiro
Cleuber F Fontes
Marco Andrey
Kedma Magalhães
Ana A Araujo
Lilian F Paffadore
Camila Marconi
Eddie F C Murta
Paulo C Fernandes
Maria S G Raddi
Penélope S Marinho
Rita B G Bornia
Jussara K Palmeiro
Libera M Dalla-Costa
Tatiana C A Pinto
Ana Caroline N Botelho
Lúcia M Teixeira
Sérgio Eduardo L FracalanzzaDepartamento de Microbiologia Médica, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. fracalanzza@micro.ufrj.br.
Universidade Federal do Rio de Janeiro · BRHospital de Clínicas Universidade Federal do Paraná · BRSabin Medicina Diagnostica (Brazil) · BRUniversidade Estadual Paulista (Unesp) · BRUniversidade Federal do Triângulo Mineiro · BRHospital Mãe de Deus · BRHospital Universitário da Universidade de São Paulo · BRHospital Universitário da Universidade Federal do Maranhão · BRInstituto de Biologia do Exército · BRUniversidade de Cuiabá · BRUniversidade Estadual de Campinas (UNICAMP) · BRUniversidade Federal da Bahia · BRUniversidade Federal do Amazonas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGroup B Streptococcus (GBS) remains a major cause of neonatal sepsis and is also associated with invasive and noninvasive infections in pregnant women and non-pregnant adults, elderly and patients with underlying medical conditions. Ten capsular serotypes have been recognized, and determination of their distribution within a specific population or geographical region is important as they are major targets for the development of vaccine strategies. We have evaluated the characteristics of GBS isolates recovered from individuals with infections or colonization by this microorganism, living in different geographic regions of Brazil.

methodsA total of 434 isolates were identified and serotyped by conventional phenotypic tests. The determination of antimicrobial susceptibility was performed by the disk diffusion method. Genes associated with resistance to erythromycin (ermA, ermB, mefA) and tetracycline (tetK, tetL, tetM, tetO) as well as virulence-associated genes (bac, bca, lmb, scpB) were investigated using PCR. Pulsed-field gel electrophoresis (PFGE) was used to examine the genetic diversity of macrolide-resistant and of a number of selected macrolide-susceptible isolates.

resultsOverall, serotypes Ia (27.6%), II (19.1%), Ib (18.7%) and V (13.6%) were the most predominant, followed by serotypes IV (8.1%) and III (6.7%). All the isolates were susceptible to the beta-lactam antimicrobials tested and 97% were resistant to tetracycline. Resistance to erythromycin and clindamycin were found in 4.1% and 3% of the isolates, respectively. Among the resistance genes investigated, tetM (99.3%) and tetO (1.8%) were detected among tetracycline-resistant isolates and ermA (39%) and ermB (27.6%) were found among macrolide-resistant isolates. The lmb and scpB virulence genes were detected in all isolates, while bac and bca were detected in 57 (13.1%) and 237 (54.6%) isolates, respectively. Molecular typing by PFGE showed that resistance to erythromycin was associated with a variety of clones.

conclusionThese findings indicate that GBS isolates circulating in Brazil have a variety of phenotypic and genotypic characteristics, and suggest that macrolide-resistant isolates may arise by both clonal spread and independent acquisition of resistance genes.

Indexed as

AdultAgedAnti-Bacterial AgentsBacterial ProteinsBrazilClindamycinDrug Resistance, Multiple, BacterialErythromycinFemaleGenetic VariationGenotypeHumansMaleMicrobial Sensitivity TestsMiddle AgedMolecular Sequence DataAnti-Bacterial AgentsBacterial ProteinsClindamycinErythromycinTetracyclineVirulence Factors

Identifiers

PMID24919844
PMCPMC4061772
OpenAlexW2109099721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.